Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicholas Tschernia
Chondroitin Sulfate Proteoglycan 4 Specific Chimeric Antigen Receptor Therapy for Pediatric Solid Tumors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Prospects to Improve Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Immunotherapy
Oncology
Allergy
Immunology
Chondroitin Sulfate Proteoglycan (CSPG)
Science-Business eXchange
Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
PLoS ONE
Multidisciplinary
394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Targeted Downregulation of N-Acetylgalactosamine 4-Sulfate 6-O-Sulfotransferase Significantly Mitigates Chondroitin Sulfate Proteoglycan-Mediated Inhibition
GLIA
Molecular Neuroscience
Neurology
Cellular
Histochemical Differentiation Between Chondroitin 4-Sulfate and Chondroitin 6-Sulfate.
Kurume Medical Journal
Medicine
